Kate Burbury

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

Constantine S. Tam, Mary Ann Anderson, Christiane Pott et al. · New England Journal of Medicine · 2018 · 417 citations

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

Theresia M. Westers, Robin Ireland, Wolfgang Kern et al. · Leukemia · 2012 · 243 citations · Full text

Hematological Malignancy, Flow Cytometry, Myelodysplastic Syndromes +12

Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation

S Kamel, Linda W. Horton, Loïc Ysebaert et al. · Leukemia · 2014 · 225 citations

Inflammation, Thrombosis, Thrombopoiesis +10

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

Anna Porwit, Arjan A. van de Loosdrecht, Peter Bettelheim et al. · Leukemia · 2014 · 145 citations

Hematological Malignancy, Flow Cytometry, Medicine +10

Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib

Chan Y. Cheah, Kate Burbury, Jane F. Apperley et al. · Blood · 2014 · 136 citations · Full text